{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:45:04Z","timestamp":1790675104139,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["bprclinrheum.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.berh.2013.07.011","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T02:16:32Z","timestamp":1384481792000},"page":"425-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pulmonary hypertension in systemic lupus erythematosus"],"prefix":"10.1016","volume":"27","author":[{"given":"Benjamin E.","family":"Schreiber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Gerry","family":"Coghlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2013.07.011_bib1","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"European Heart Journal"},{"key":"10.1016\/j.berh.2013.07.011_bib2","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","article-title":"ACCF\/AHA 2009 expert consensus document on pulmonary hypertension","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2013.07.011_bib3","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.berh.2013.07.011_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0049-0172(84)90015-5","article-title":"Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus","volume":"13","author":"Quismorio","year":"1984","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2013.07.011_bib5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.hdx.0000089834.97829.5e","article-title":"Valvular heart disease and systemic lupus erythematosus: therapeutic implications","volume":"5","author":"Fluture","year":"2003","journal-title":"Heart Disease"},{"key":"10.1016\/j.berh.2013.07.011_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0b013e31829dd857","article-title":"Atherosclerosis in systemic lupus erythematosus","author":"Stojan","year":"2013","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.berh.2013.07.011_bib7","doi-asserted-by":"crossref","first-page":"iv8","DOI":"10.1093\/rheumatology\/kel308","article-title":"Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus","volume":"45","author":"Tincani","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2013.07.011_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01451282","article-title":"A multicenter study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analysis of clinical subsets","volume":"17","author":"Jacobsen","year":"1998","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.berh.2013.07.011_bib9","doi-asserted-by":"crossref","DOI":"10.1113\/jphysiol.2013.253682","article-title":"Hypoxic pulmonary vasoconstriction in the absence of pretone: essential role for intracellular Ca2+ release","author":"Connolly","year":"2013","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.berh.2013.07.011_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0025-6196(11)61030-6","article-title":"Pulmonary hypertension in patients with interstitial lung diseases","volume":"82","author":"Ryu","year":"2007","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.berh.2013.07.011_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0961203309360541","article-title":"Update on anti-phospholipid antibodies in SLE: the Hopkins' lupus cohort","volume":"19","author":"Petri","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2013.07.011_bib12","doi-asserted-by":"crossref","first-page":"A53","DOI":"10.1186\/ar3987","article-title":"Risk of pulmonary embolism and deep vein thrombosis in systemic lupus erythematosus: a population-based cohort study","volume":"14","author":"Avi\u00f1a-Zubieta","year":"2012","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.berh.2013.07.011_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1183\/09031936.00087608","article-title":"Risk factors for chronic thromboembolic pulmonary hypertension","volume":"33","author":"Bonderman","year":"2009","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.berh.2013.07.011_bib14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1177\/0961203309106601","article-title":"Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies","volume":"18","author":"Quadrelli","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2013.07.011_bib15","first-page":"1","article-title":"Pulmonary hypertension and systemic lupus erythematosus","volume":"13","author":"Asherson","year":"1986","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2013.07.011_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000196025","article-title":"Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus","volume":"59","author":"Roncoroni","year":"1992","journal-title":"Respiration"},{"key":"10.1016\/j.berh.2013.07.011_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.autrev.2012.07.010","article-title":"Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy","volume":"12","author":"Ruiz-Irastorza","year":"2013","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.berh.2013.07.011_bib18","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/rheumatology\/kep203","article-title":"Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus","volume":"48","author":"Prabu","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2013.07.011_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1191\/0961203306lu2305xx","article-title":"Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden","volume":"15","author":"Danchenko","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2013.07.011_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.berh.2013.07.011_bib21","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.berh.2013.07.011_bib22","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.berh.2013.07.011_bib23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.104.503540","article-title":"Pulmonary arterial hypertension","volume":"114","author":"McLaughlin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2013.07.011_bib24","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1172\/JCI60658","article-title":"Molecular pathogenesis of pulmonary arterial hypertension","volume":"122","author":"Rabinovitch","year":"2012","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2013.07.011_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2010.09.001","article-title":"Key role of the RhoA\/Rho kinase system in pulmonary hypertension","volume":"24","author":"Connolly","year":"2011","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"10.1016\/j.berh.2013.07.011_bib26","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.37934","article-title":"Enhanced Rho-associated protein kinase activation in patients with systemic lupus erythematosus","volume":"65","author":"Isgro","year":"2013","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.011_bib27","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00296-012-2659-y","article-title":"Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis","volume":"33","author":"Shahane","year":"2013","journal-title":"Rheumatology International"},{"key":"10.1016\/j.berh.2013.07.011_bib28","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/art.10442","article-title":"Pulmonary hypertension in autoimmune rheumatic diseases: where are we now?","volume":"46","author":"Magliano","year":"2002","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.011_bib29","first-page":"2058","article-title":"Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus","volume":"21","author":"Yoshio","year":"1994","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2013.07.011_bib30","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/ard.2005.035295","article-title":"Antiendothelial cell antibodies in vasculitis and connective tissue disease","volume":"65","author":"Belizna","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2013.07.011_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s002960050074","article-title":"Pulmonary hypertension in systemic lupus erythematosus","volume":"18","author":"Shen","year":"1999","journal-title":"Rheumatology International"},{"key":"10.1016\/j.berh.2013.07.011_bib32","doi-asserted-by":"crossref","first-page":"854941","DOI":"10.1155\/2012\/854941","article-title":"Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction","volume":"2012","author":"Dhala","year":"2012","journal-title":"Clinical and Developmental Immunology"},{"key":"10.1016\/j.berh.2013.07.011_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2332\/allergolint.11-RAI-0337","article-title":"A histopathological study of pulmonary hypertension in connective tissue disease","volume":"60","author":"Sasaki","year":"2011","journal-title":"Allergology International"},{"key":"10.1016\/j.berh.2013.07.011_bib34","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.berh.2013.07.011_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00296-009-1255-2","article-title":"Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome","volume":"31","author":"Cefle","year":"2011","journal-title":"Rheumatology International"},{"key":"10.1016\/j.berh.2013.07.011_bib36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3399\/bjgp12X658467","article-title":"Pulmonary hypertension: a guide for GPs","volume":"62","author":"Connolly","year":"2012","journal-title":"British Journal of General Practice"},{"key":"10.1016\/j.berh.2013.07.011_bib37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1378\/chest.12-0270","article-title":"Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension","volume":"143","author":"Fritz","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.berh.2013.07.011_bib38","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00296-011-1880-4","article-title":"Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus","volume":"32","author":"Lian","year":"2012","journal-title":"Rheumatology International"},{"key":"10.1016\/j.berh.2013.07.011_bib39","first-page":"40","article-title":"Diagnosis and prognosis of pulmonary arterial hypertension in SLE and SSc","volume":"50","author":"Schreiber","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2013.07.011_bib40","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1111\/j.1756-185X.2012.01815.x","article-title":"Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry","volume":"15","author":"Jeon","year":"2012","journal-title":"International Journal of Rheumatic Disease"},{"key":"10.1016\/j.berh.2013.07.011_bib41","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2967\/jnumed.106.039438","article-title":"Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension","volume":"48","author":"Tunariu","year":"2007","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.berh.2013.07.011_bib42","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/eurheartj\/ehq170","article-title":"Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension","volume":"31","author":"Montani","year":"2010","journal-title":"European Heart Journal"},{"key":"10.1016\/j.berh.2013.07.011_bib43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for PPH","volume":"334","author":"Barst","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.berh.2013.07.011_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/eurheartj\/ehp022","article-title":"A meta-analysis of randomized controlled trials in pulmonary arterial hypertension","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"European Heart Journal"},{"key":"10.1016\/j.berh.2013.07.011_bib45","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.112.000765","article-title":"Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study","volume":"127","author":"Hoeper","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2013.07.011_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1378\/chest.117.1.14","article-title":"Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus","volume":"117","author":"Robbins","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.berh.2013.07.011_bib47","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.rmed.2007.05.020","article-title":"Lupus-associated pulmonary hypertension: long-term response to vasoactive therapy","volume":"101","author":"Heresi","year":"2007","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.berh.2013.07.011_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s10165-012-0828-1","article-title":"Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center","author":"Shirai","year":"2013","journal-title":"Modern Rheumatology"},{"key":"10.1016\/j.berh.2013.07.011_bib49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0961203312462265","article-title":"The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis","volume":"22","author":"Mavrogeni","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2013.07.011_bib50","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1177\/0961203312456752","article-title":"A contemporary case series of lupus myocarditis","volume":"13","author":"Zawadowski","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2013.07.011_bib51","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1177\/0961203307087610","article-title":"Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report","volume":"17","author":"Hennigan","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2013.07.011_bib52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.011_bib53","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s10067-006-0206-5","article-title":"Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension","volume":"25","author":"Chung","year":"2006","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.berh.2013.07.011_bib54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2013.07.011_bib55","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.berh.2013.07.011_bib56","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1183\/09031936.00057010","article-title":"Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension","volume":"36","author":"Humbert","year":"2010","journal-title":"European Respiratory Journal"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694213000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694213000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T15:21:18Z","timestamp":1539184878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694213000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1521694213000636"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2013.07.011","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary hypertension in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2013.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}